Buscar resultados de ensayos clínicos

Patrocinado por

Edema - 308 Studies Found

Estado Estudiar
Completed Nombre del estudio: Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condición: Hereditary Angioedema
Fecha: 2007-04-04
Intervenciones:
  • Drug: ecallantide dose of 30 m
Completed Nombre del estudio: Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema
Condición: ACE-I and ARB-induced Angioedema.
Fecha: 2016-07-05
Active, not recruiting Nombre del estudio: A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Condición: Hereditary Angioedema (HAE)
Fecha: 2011-06-28
Intervenciones: Drug: icatibant Single dose of icatibant 0.4 mg/kg subcutaneous(SC) up to a maximal dose of 30 mg
Completed Nombre del estudio: Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema
Condición: Acute ACE-induced Angioedema
Fecha: 2013-04-26
Intervenciones:
  • Drug: Berinert
  • Drug: Clemastin
Completed Nombre del estudio: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
Condición: Hereditary Angioedema Types I and II
Fecha: 2013-04-04
Intervenciones: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc
Completed Nombre del estudio: A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Condición: Hereditary Angioedema (HAE)
Fecha: 2012-02-16
Completed Nombre del estudio: Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condición: Hereditary Angioedema (HAE)
Fecha: 2005-12-05
Intervenciones:
  • Drug: ecallantide dose of 30 m
Completed Nombre del estudio: Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema
Condición: Hereditary Angioedema (HAE)
Fecha: 2016-08-10
Intervenciones:
  • Drug: BCX7353 Plasma kallikrei
Completed Nombre del estudio: Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema
Condición: Hereditary Angioedema (HAE)
Fecha: 2014-01-30
Intervenciones:
  • Biological: CINRYZE 500 500 Un
Active, not recruiting Nombre del estudio: Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)
Condición: Hereditary Angioedema (HAE)
Fecha: 2016-08-09
Intervenciones:
  • Drug: CINRYZE 500 U IV infusio
<<< Previous | Next >>>